Hospira Spin-Off From Abbott "Progressing Smoothly," CEO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Under a Transition Services Agreement, Abbott will sell Hospira products abroad until the hospital company develops an international infrastructure. Hospira expects three product launches in 2005.